Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Vaccinex's revenue for the twelve months ending Dec 31, 2024 was $601.00K, up 5.4% year over year. For fiscal 2024 it was $601.00K, up 5.4% from the year before. The highest annual figure on record is $900.00K in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $601.00K | +5.4% |
| FY2023 | Dec 31, 2023 | $570.00K | +107.3% |
| FY2022 | Dec 31, 2022 | $275.00K | -69.4% |
| FY2021 | Dec 31, 2021 | $900.00K | +44.0% |
| FY2020 | Dec 31, 2020 | $625.00K | +19.5% |
| FY2019 | Dec 31, 2019 | $523.00K | -27.8% |
| FY2018 | Dec 31, 2018 | $724.00K | +704.4% |
| FY2017 | Dec 31, 2017 | $90.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $213.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $52.00K | +160.0% |
| Q2 FY2024 | Jun 30, 2024 | $232.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $104.00K | -81.1% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $20.00K | -60.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $550.00K | +1000.0% |
| Q4 FY2022 | Dec 31, 2022 | $225.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $50.00K | -94.1% |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $50.00K | -92.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $850.00K | +110.4% |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $625.00K | +564.9% |
| Q4 FY2019 | Dec 31, 2019 | $0 | -100.0% |
| Q3 FY2019 | Sep 30, 2019 | $404.00K | +104.0% |
| Q2 FY2019 | Jun 30, 2019 | $25.00K | -80.2% |
| Q1 FY2019 | Mar 31, 2019 | $94.00K | -54.4% |
| Q4 FY2018 | Dec 31, 2018 | $194.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $198.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $126.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $206.00K | – |
See a number that looks wrong?